SightfileU.S. market data from official filings

Pliant Therapeutics Inc (PLRX)

Name: Pliant Therapeutics Inc (PLRX) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001746473 · EDGAR filings · Updated 2026-07-13

Pliant Therapeutics Inc (PLRX) has reported institutional ownership of 80.2%, with 91 institutional managers holding positions valued at $62.5M per the latest 13F reporting period.

Institutional ownership

80.2%

Institutional managers

Reported 13F value

$62.5M

Insider activity

4 trans.

−$163.6K net selling

Latest updates

2026-07-13 — Initial insider ownership filed (Form 3)
2026-07-13 — Insider transaction reported (Form 4)
2026-07-13 — Initial insider ownership filed (Form 3)
2026-07-13 — Insider transaction reported (Form 4)
2026-07-13 — Current report (8-K) filed
2026-06-12 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Pliant Therapeutics Inc has 91 institutional holders and institutional ownership of 80.2%.

Insider activity

Insiders reported 4 transactions (0 buys, 4 sells) across 4 reporting insiders, with a net reported value of −$163.6K.

Related companies

HUTCHMED CHINA LTD (HCM) · Achieve Life Sciences Inc (ACHV) · ALDEYRA THERAPEUTICS INC (ALDX) · AVITA MEDICAL INC (RCEL) · NEURONETICS INC (STIM) · ALPHA COGNITION INC (ACOG)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-13.